Zealand Pharma A/S Logo

Zealand Pharma A/S (22Z)

XETR

Currency in EUR
33.30
-1.64 (-4.69%)

Real-time Data

07:00 AM

Day's Range

32.84
33.84

52 wk Range

31.45
73.90

Financial Statements - 22Z - Zealand Pharma A/S

Revenue

9.21B

Net Income

6.45BNet Margin 70.0%

EBITDA

7.14B

Free Cash Flow

6.46B

Income Statement

Period Ending2025-12-31
Sales9.21B
Cost of Goods816K
Gross Profit9.21B
ExpandOperating Expense
-
Operating Income7.11B
ExpandNon-Operating Interest
-
Other Income Expense-
Pre Tax Income7B
Income Tax546.05M
Net Income6.45B
EPS Basic91.56
EPS Diluted90.22
Basic Shares Outstanding70.50M
Diluted Shares Outstanding70.50M
Ebit7.03B
Ebitda7.14B
Net Income Continuous Operations6.45B
Minority Interests-
Preferred Stock Dividends0

The information on this page is provided for general informational purposes only and is not investment advice.

Market data provided by Twelve Data. Charting by TradingView.

Last updated:

Track Global Markets in Real Time with UA Finance

Download the app now and access live financial data, expert analysis, and trusted economic news to follow stocks, forex, gold, and cryptocurrencies with ease.